Pharma companies cheer lower drug prices, API tax gap stirs worry

Goods and Services Tax reforms are expected to reduce medicine prices in India. Experts say this will benefit patients and businesses. However, concerns exist regarding the higher tax rate on Active Pharmaceutical Ingredients. This could increase working capital pressure, especially for smaller companies. Provisional refunds may help mitigate these challenges. The government has reduced GST on several expensive medicines.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/rJcQTk6
via IFTTT